Correlation Between Medigus and Entera Bio

Can any of the company-specific risk be diversified away by investing in both Medigus and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigus and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigus Ltd WT and Entera Bio, you can compare the effects of market volatilities on Medigus and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigus with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigus and Entera Bio.

Diversification Opportunities for Medigus and Entera Bio

0.0

Correlation Coefficient

Medigus  Entera Bio

Pay attention - limited upside

The 3 months correlation between Medigus and Entera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Medigus Ltd WT and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Medigus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigus Ltd WT are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Medigus i.e., Medigus and Entera Bio go up and down completely randomly.

Pair Corralation between Medigus and Entera Bio

If you would invest  0.12  in Entera Bio on October 23, 2024 and sell it today you would earn a total of  0.00  from holding Entera Bio or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medigus Ltd WT  vs.  Entera Bio

Medigus Ltd WT

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigus Ltd WT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medigus is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Entera Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Entera Bio is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Medigus and Entera Bio

The main advantage of trading using opposite Medigus and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigus position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.

The idea behind Medigus Ltd WT and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.